logo

Italy set to speed through $2.3bln Novo Nordisk investment

Zawya07-07-2025
Italian authorities on Monday appointed a special commissioner to help Danish drugmaker Novo Nordisk speedily deliver its promised 2 billion-euro ($2.34 billion) investment in a factory south of Rome.
As part of Novo Holdings' takeover of pharmaceutical company Catalent last year, Novo Nordisk acquired a site in Italy along with two others, one in Belgium and one in the United States.
Francesco Rocca, president of the Lazio region that includes Rome and is where the Anagni factory is based, was made special commissioner for the site, a role giving him powers to speed up projects related to the facility, including upgrades.
The factory will produce weight loss and anti-diabetes drugs, the region said in a statement, adding that Rocca's appointment "aims to ensure administrative speed and institutional coordination, essential elements for a project of this magnitude".
Italy's government approved Novo's plans to upgrade capacity at the Anagni site in March, saying the company had pledged to invest more than 2 billion euros in 2025-2029 and hire around 800 people, boosting the total workforce to 1,500.
The government declared the plans to be of "pre-eminent strategic interest", a status granted to large foreign investment projects that allows the fast-tracking of approval procedures.
($1 = 0.8530 euros)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Italy set to speed through $2.3bln Novo Nordisk investment
Italy set to speed through $2.3bln Novo Nordisk investment

Zawya

time07-07-2025

  • Zawya

Italy set to speed through $2.3bln Novo Nordisk investment

Italian authorities on Monday appointed a special commissioner to help Danish drugmaker Novo Nordisk speedily deliver its promised 2 billion-euro ($2.34 billion) investment in a factory south of Rome. As part of Novo Holdings' takeover of pharmaceutical company Catalent last year, Novo Nordisk acquired a site in Italy along with two others, one in Belgium and one in the United States. Francesco Rocca, president of the Lazio region that includes Rome and is where the Anagni factory is based, was made special commissioner for the site, a role giving him powers to speed up projects related to the facility, including upgrades. The factory will produce weight loss and anti-diabetes drugs, the region said in a statement, adding that Rocca's appointment "aims to ensure administrative speed and institutional coordination, essential elements for a project of this magnitude". Italy's government approved Novo's plans to upgrade capacity at the Anagni site in March, saying the company had pledged to invest more than 2 billion euros in 2025-2029 and hire around 800 people, boosting the total workforce to 1,500. The government declared the plans to be of "pre-eminent strategic interest", a status granted to large foreign investment projects that allows the fast-tracking of approval procedures. ($1 = 0.8530 euros)

Italy raises concerns over false info from DeepSeek
Italy raises concerns over false info from DeepSeek

Tahawul Tech

time17-06-2025

  • Tahawul Tech

Italy raises concerns over false info from DeepSeek

Italian antitrust watchdog AGCM said recently it had opened an investigation into Chinese AI startup DeepSeek for allegedly failing to warn users that it may produce false information. The Italian regulator said in a statement DeepSeek did not give users 'sufficiently clear, immediate and intelligible' warnings about the risk of so-called 'hallucinations' in its AI-produced content. It described these as 'situations in which, in response to a given input entered by a user, the AI ​​model generates one or more outputs containing inaccurate, misleading or invented information.' In February, another Italian watchdog, the data protection authority, ordered DeepSeek to block access to its chatbot after it failed to address its concerns on privacy policy. Source: Reuters Image Credit: Stock Image/DeepSeek

European shares stable as markets eye China-US trade talks
European shares stable as markets eye China-US trade talks

Al Etihad

time10-06-2025

  • Al Etihad

European shares stable as markets eye China-US trade talks

10 June 2025 11:50 EU (REUTERS) European stocks were steady on Tuesday, shrugging off modest losses from the previous session, as investors stayed on edge awaiting fresh signals from the second day of tense US-China trade continent-wide STOXX 600 held its ground at 553.12 points, as of 0703 spotlight remains on the talks in London between the world's two biggest economies, as investors eagerly watch for any signs of progress or a thaw in President Donald Trump on Monday put a positive spin on the talks, without providing any details on how the trade war, which has threatened to disrupt global supply chains, could in automakers, which rose 1%, were offset by financial services and industrial shares, which fell 0.8% and 0.4%, stocks, Novo Nordisk gained nearly 2% after a report said activist hedge fund Parvus Asset Management is building a stake in the gained 4% after the British homebuilder raised its forecast for full-year volume production. Shares of Aberdeen gained 5% after upgraded the fund manager's stock to "overweight" from "neutral."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store